Day One Biopharmaceuticals Inc

NASDAQ:DAWN   3:59:55 PM EDT
22.74
-1.65 (-6.76%)
Earnings Announcements

Day One Reports Second Quarter 2022 Financial Results And Corporate Progress

Published: 08/04/2022 21:34 GMT
Day One Biopharmaceuticals Inc (DAWN) - Day One Reports Second Quarter 2022 Financial Results and Corporate Progress.
Qtrly Net Loss per Share, Basic and Diluted $0.60.
Cash, Cash Equivalents and Short-term Investments Totaled $394.9 Million on June 30, 2022.
Q2 Earnings per Share View $-0.49 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.